Mark Higgins

4.4k citations
75 papers · 3.0k · 1 hit paper · h-index 26

Impact in

    • Cystic Fibrosis Research Advances
    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Neonatal Respiratory Health Research
    • Inhalation and Respiratory Drug Delivery
    • Tracheal and airway disorders
    • Respiratory Support and Mechanisms
    • Respiratory and Cough-Related Research
  • Physiology top 2%
    • Asthma and respiratory diseases

Papers in

    • Cystic Fibrosis Research Advances 23
    • Chronic Obstructive Pulmonary Disease (COPD) Research 22
    • Inhalation and Respiratory Drug Delivery 10
    • Respiratory Support and Mechanisms 9
    • Neonatal Respiratory Health Research 4
    • Asthma and respiratory diseases 14

Mark Higgins

69 papers receiving 2.8k citations

Mark Higgins's Hit Papers

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation 2014 · 290 citations
2900+4+8Years since publication50100150200250

Peers

Mark Higgins
Comparison fields: 5 of 114
  • Pulmonary and Respiratory Medicine 2.4k
  • Physiology 763
  • Molecular Medicine 46
  • Issues, ethics and legal aspects 10
  • Statistics and Probability 68
Replace Edward D. Lustbader with:
Edward D. Lustbader United States
Thomas J. Hwang United States
Jeongeun Kim South Korea
Michael P. Douglas United States
André Ilbawi Switzerland
Jonathan J. Darrow United States
Catherine H. Marshall United States
Mark R. Wakefield United States
Jennifer L. Johnson United States
Jennifer Sims United States
Mark Higgins relative to Edward D. Lustbader United States Edward D. Lustbader's profile →
Citations per field
00.5×10×20×31.7×
Edward D. Lustbader · 1×
Citations per year

Countries citing papers authored by Mark Higgins

Since Specialization
Citations

This map shows the geographic impact of Mark Higgins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Higgins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Higgins more than expected).

Fields of papers citing papers by Mark Higgins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Higgins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Higgins. The network helps show where Mark Higgins may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Higgins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Higgins Line = papers co-authored together Mark Higgins links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
Hit paper breakdown →
2014290
2 2010282
3 2010266
4 2010218
5 2019194
6 2015181
7 2018153
8 2010103
9 201995
10 201085
11 199781
12 200877
13 200671
14 201067
15 199565
16 200754
17 200740
18 201739
19 201339
20 200738

About Mark Higgins

Mark Higgins is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Accounting, Cardiology and Cardiovascular Medicine and Animal Science and Zoology, having authored 75 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (23 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Asthma and respiratory diseases (14 papers), Inhalation and Respiratory Drug Delivery (10 papers), Respiratory Support and Mechanisms (9 papers), Pharmacological Effects and Assays (4 papers), Neonatal Respiratory Health Research (4 papers) and Pediatric health and respiratory diseases (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.4k citations), Physiology (763 citations), Molecular Medicine (46 citations), Issues, ethics and legal aspects (10 citations) and Statistics and Probability (68 citations). Mark Higgins has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Roger Owen, Benjamin Krämer, Damon Jack, Michael W. Konstan, Patrick A. Flume, Amir Iqbal, K. De Boeck, À. Munck, Geoffrey Gilmartin and Peter Hiatt. Their work appears in journals such as Journal of Cystic Fibrosis, Respiratory Medicine, Thorax, Current Medical Research and Opinion and Pulmonary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact